Physician

Chad Allan Peterson, M.D.

According to 2025 Medicare claims, Chad Peterson, M.D. (NPI: 1629284732) practices urology in the Coeur d'Alene, ID market, with the plurality of this provider's patient population coming from Kootenai, ID. This provider's primary affiliated billing organization is NORTH IDAHO UROLOGY, PLLC (NPI: 1891834768; TIN: 82-0533076) and primary practice location at 83814-2668. Peterson is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), participating under the MSSP model.

Peterson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 801 traditional Medicare patients, billed 10,044 HCPCS/CPT codes, and received $421,454 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,628 prescription claims across 568 beneficiaries totaling $3,808,984 in drug costs, led by Xtandi (Enzalutamide). DME data shows 74 claims. Open Payments data shows 49 records totaling $1,330. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $230,803 and ending at $421,454. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $132,737 to $3,808,984. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $609 and ending at $314.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	611	17,198	$230,803
2016	652	17,529	$324,445
2017	688	16,683	$432,484
2018	784	11,781	$300,659
2019	798	13,065	$417,154
2020	752	15,035	$270,676
2021	735	15,075	$283,247
2022	754	14,101	$317,844
2023	752	8,421	$281,812
2024	801	10,044	$421,454

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	336	1,356	$132,737
2016	348	1,369	$168,781
2017	369	1,532	$186,501
2018	416	1,882	$740,312
2019	441	1,782	$682,734
2020	361	1,563	$896,553
2021	392	1,698	$1,339,343
2022	528	2,246	$2,328,223
2023	489	2,244	$3,305,577
2024	568	2,628	$3,808,984

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	139	$40,492
2016	N/R	86	$30,104
2017	N/R	74	$37,292
2018	N/R	121	$39,168
2019	N/R	99	$30,384
2020	11	90	$29,775
2021	N/R	60	$26,707
2022	14	85	$35,564
2023	14	83	$49,197
2024	11	74	$42,115

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	419	647	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	217	241	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	397	578	$12
81001	Manual urinalysis test with examination using microscope, automated	230	366	$3
81003	Automated urinalysis test	252	292	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	169	5,070	$2,328,818
Orgovyx	Relugolix	376	11,280	$979,207
Yonsa	Abiraterone Acet,submicronized	25	750	$247,123
Nubeqa	Darolutamide	11	330	$142,989
Myrbetriq	Mirabegron	59	2,704	$38,710

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	22	$23,198
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	11	37	$18,651
A4332	Lubricant, individual sterile packet, each	N	N/R	15	$266

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$1,330	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chad Allan Peterson, M.D.?

Tedicare shows public-source Medicare data for Chad Allan Peterson, M.D. (NPI 1629284732), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chad Allan Peterson, M.D. have ACO affiliation data?

Chad Allan Peterson, M.D. is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621).

What billing organization is linked to Chad Allan Peterson, M.D.?

Chad Allan Peterson, M.D. is linked to NORTH IDAHO UROLOGY, PLLC (billing NPI 1891834768) in the available physician profile data.

Does Chad Allan Peterson, M.D. have Open Payments data?

Chad Allan Peterson, M.D. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.